Stay updated on RP-A601 in PKP2-ACM Clinical Trial
Sign up to get notified when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.

Latest updates to the RP-A601 in PKP2-ACM Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded site revision tag Revision: v3.4.2 and removed the funding-status notice and the previous revision notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange DetectedNotice explains that due to a lapse in government funding, site information may not be up to date and transactions may not be processed until appropriations are enacted. It also states the NIH Clinical Center is open and provides status links (cc.nih.gov and opm.gov); the page version is updated to v3.4.1.SummaryDifference0.5%

- Check52 days agoChange DetectedUI and metadata updates were applied, including a new 'Show glossary' option and updated QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria') along with the revision text (v3.4.0), while older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedInvestigators, sponsors, and locations (including principal investigator names and contact details) have been removed, along with related study sections and MeSH terms. This reduces visibility of who is conducting the trial and where it is conducted.SummaryDifference16%

Stay in the know with updates to RP-A601 in PKP2-ACM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP-A601 in PKP2-ACM Clinical Trial page.